Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...
So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.
It marked a significant slowdown for the drug considering it remains in its early launch phase, delivering 26% sequential growth in the prior quarter. The rollout suffered a “temporary impact ...
The indications for antiarrhythmic drug therapy have not changed ... and persistent AF: the flow charts are not different by AF pattern. This simplification is supported by two observations: the time ...
Current antiarrhythmic drugs for AF have limited ... and atrial remodeling. Class III drugs sotalol, dofetilide and ibutilide target reentry by prolonging the atrial effective refractory period ...
β-blockers are effective ventricular antiarrhythmics and angiotensin-converting-enzyme (ACE) inhibitors can prevent both ventricular and atrial arrhythmia after MI. The effect of β-blockers on ...
Following on from the three warrants that were executed by Scarborough CID on Wednesday January 23, three men were arrested and have subsequently been charged with a total of 11 offences combined. Did ...
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...
So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ...
Eric Clapton’s fifth solo album Slowhand debuts on Billboard's Top Blues Albums chart at No. 2, ... [+] nearly netting the guitarist another No. 1. British guitarist Eric Clapton performing on ...
Amiodarone, a class III antiarrhythmic agent ... be due to the fact that intravenous administration allows the drug to rapidly enter the circulatory system, thereby expediting its effects.